Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
According to industry insiders, the UK has the chance to set new policies that will both keep the domestic IVD market safe, while keeping the country internationally competitive.
Biden Administration Details Expanded Testing as Part of Broader COVID-19 Action Plan
President Biden said he would use the Defense Production Act to expand manufacturing of rapid point-of-care and at-home COVID-19 tests, among other initiatives. Â
Of particular significance are details on exactly how billing disputes will be filed and adjudicated under the law, which is currently in the public comment period.
State-Regulated Illinois Health Plans Subject to Biomarker Test Coverage Mandate Starting 2022
Premium
The law requires state employee, Medicaid, public school, and small employer plans to cover evidence-based biomarker testing, a change that will readily impact cancer patients.
Pressure from payors and newer high-priced assays have expanded the gap between independent labs and hospital outreach businesses.